How Is The Market Feeling About CNS Pharma?
Portfolio Pulse from Benzinga Insights
CNS Pharma (NYSE:CNSP) has seen a significant rise in its short percent of float, now at 53.52%. This indicates increased bearish sentiment among investors. The company's short interest is much higher than its peers, which average 8.77%.
June 18, 2024 | 8:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CNS Pharma's short percent of float has surged to 53.52%, indicating a significant increase in bearish sentiment. This could lead to heightened volatility in the stock's price.
The substantial increase in short interest suggests that many investors are betting against CNS Pharma, which could lead to downward pressure on the stock price. The high short interest compared to peers indicates a particularly negative sentiment towards CNSP.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100